First Time Loading...

Shenzhen YHLO Biotech Co Ltd
SSE:688575

Watchlist Manager
Shenzhen YHLO Biotech Co Ltd Logo
Shenzhen YHLO Biotech Co Ltd
SSE:688575
Watchlist
Price: 24.29 CNY 3.05% Market Closed
Updated: Jun 1, 2024
Shenzhen YHLO Biotech Co Ltd
/
Income Statement
/
Income from Continuing Operations

Shenzhen YHLO Biotech Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shenzhen YHLO Biotech Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
A
688617
J
002223
300760
L
300003
688271

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Shenzhen YHLO Biotech Co Ltd
SSE:688575
Income from Continuing Operations
¥279.2m
CAGR 3-Years
10%
CAGR 5-Years
49%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Income from Continuing Operations
¥522.1m
CAGR 3-Years
71%
CAGR 5-Years
99%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Income from Continuing Operations
¥2.3B
CAGR 3-Years
8%
CAGR 5-Years
25%
CAGR 10-Years
24%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Income from Continuing Operations
¥12.2B
CAGR 3-Years
20%
CAGR 5-Years
25%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Income from Continuing Operations
¥1.2B
CAGR 3-Years
-20%
CAGR 5-Years
-5%
CAGR 10-Years
12%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Income from Continuing Operations
¥2B
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Shenzhen YHLO Biotech Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
279.2m CNY

Based on the financial report for Dec 31, 2023, Shenzhen YHLO Biotech Co Ltd's Income from Continuing Operations amounts to 279.2m CNY.

What is Shenzhen YHLO Biotech Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
49%

Over the last year, the Income from Continuing Operations growth was -73%. The average annual Income from Continuing Operations growth rates for Shenzhen YHLO Biotech Co Ltd have been 10% over the past three years , 49% over the past five years .

ALPHA SPREAD
Join more than 142,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.